October 2009 - Page 26 of 34

ThursdayOct 08, 2009 10:23 am

Emisphere Technologies, Inc. (EMIS.OB) Introduces First Commercially Available Product

Emisphere Technologies Inc. announced today that the company is introducing and launching its first commercially available product, oral Eligen B12 (100 mcg). This product has been specifically developed to help improve Vitamin B12 absorption and bioavailability with a patented formulation. In a trial with healthy subjects conducted last year, Eligen B12 resulted in a ten-fold increase in peak serum B12 blood levels, a two-fold improvement in total bioavailability and a reduction in absorption time greater than 90% as compared to standard oral commercial formulations. Eligen B12 has impressed others in the nutritional field. Dr. Michael Rothkopf, M.D., the director of…

ThursdayOct 08, 2009 9:33 am

Helen of Troy Ltd. (HELE) Posts Q2, Half-Year Results with Record Sales

Helen of Troy Ltd. designs, develops and markets brand-name personal care and household consumer products. The company yesterday announced its financial results for the second quarter and half-year ended August 31, 2009, posting increases in net earnings and record sales. The company posted second-quarter sales at $162.19 million, up 5.6 percent from $153.54 million for the second quarter of 2008. Second-quarter net earnings were $15.91 million, or $0.51 per fully diluted share, as compared to $10.60 million, or $0.34 per fully diluted share, for the same period last year. The company reported sales for the six months ended August 31,…

ThursdayOct 08, 2009 9:29 am

AVANIR Pharmaceuticals, Inc. (AVNR) Receives U.S. Patent for Zenvia™

AVANIR Pharmaceuticals, Inc., a biopharmaceutical company focused on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders, recently announced that the company has received a “Notice of Allowance” from the United States Patent and Trademark Office (USPTO) for its lead drug candidate Zenvia™, a treatment pseudobulbar affect (PBA). This patent will provide AVANIR Pharmaceuticals commercial exclusivity for PBA indication well into 2025. AVANIR Pharmaceuticals also has exclusive rights to other patents and patent applications for treating PBA, chronic pain and other neurologic conditions using combinations of dextromethorphan and quinidine. Greg Flesher, vice president of…

ThursdayOct 08, 2009 9:26 am

Hana Biosciences, Inc. (HNAB.OB) Announces $12.4 Million Private Placement

Hana Biosciences is a company that is clearly moving in the right direction. The company's lead product candidate, Marquibo, has been developed to help all cancer patients battle the deadly disease and with news released today, the concept has a great deal of backing. The young California Company announced there is a definite agreement in place with accredited investors to sell units consisting of common stocks and warrants which will result in total cash proceeds of $12.4 million the closing of which is expected to occur prior to October 9th with Piper Jaffray and Co. serving as exclusive place agent…

ThursdayOct 08, 2009 8:59 am

Rahaxi, Inc. (RHXI.OB) Announces Agreement with Largest Jeweller Group in Scandinavia

Rahaxi, Inc., an international card payments processor and technology company, today told investors that its subsidiary Rahaxi Processing Oy and jeweller chain giant Kultajousi Oy have entered into an agreement to supply its OTI solution to over 60 different stores in 27 different cities in Finland. Kultajousi is owned by Golden Heights Group which has a notable presence in Sweden through its subsidiary Golden Heights AB Group. Fionn Stakelum, MD of Rahaxi, Inc. stated, "To team up with the largest high end jewellers in Scandinavia is testament to the reputation of Rahaxi's OTI solution in the marketplace. Enabling us to…

ThursdayOct 08, 2009 7:52 am

Muscle Flex, Inc. (MFLI.PK) Announces New Product Portfolio in the “Water” Category

Muscle Flex Inc. announced this morning that it is developing a portfolio of "Water" related products. With plans to market using its direct response, online ecommerce and traditional retail methods, the water related products will be included as one of the company’s main product categories. Muscle Flex credits "Water" as potentially the most important ingredient in maintaining a healthy lifestyle. It has been estimated that as much as 75% of Americans do not drink enough good clean water. Water consumption is one of Danny Alex's, the CEO and Founder of Muscle Flex Inc., 30 fitness rules to living a better…

ThursdayOct 08, 2009 7:36 am

Omnicity Corp. (OMCY.OB) Signs Comprehensive Satellite Internet Delivery Agreement; Leaves No Home Behind

Yesterday after the closing bell, Omnicity Corp. announced that it has signed an agreement with StarBand Communications Inc., a leading international satellite internet service provider. Through StarBand, the company will offer satellite high speed internet service in markets throughout the United States. Omnicity will rebrand this service as Omnicity Satellite Internet Services, intending to offer it to households that may not be able to receive Omnicity's wireless internet or DSL services. Planning to immediately launch this rebranded satellite service in all its markets, Omnicity will have a high speed internet solution for virtually every household in its markets. Omnicity Satellite…

WednesdayOct 07, 2009 2:18 pm

Prime Star Group (PSGI.OB) Up 48.7% Following Recent Mention by QualityStocks Newsletter

The stock of Prime Star Group Inc. is currently trading at $0.171, up $0.056 or 48.7% for the day. This strong move has occurred on heavy volume in excess of 1 million shares, which is about ten times the stock’s average daily volume. Prime Star Group was highlighted in QualityStocks FREE Daily Newsletter on September 8th at a price of $0.10, which is a solid 70%+ return in less than a month. Prime Star is a holding company that focuses on food & beverages, distribution and SmartPax packaging. The company recently announced an alliance with the subsidiary of another company…

WednesdayOct 07, 2009 2:00 pm

Biostar Pharmaceuticals, Inc. (BSPM.OB) Receives Clearance in China to Begin Clinical Trial for Zushima Analgesic Aerosol Spray

Biostar Pharmaceuticals Inc., through its wholly-owned subsidiary in China, develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The company announced today that the Chinese Military Drug Administration has granted clearance to begin clinical trials on their new drug application, the Zushima Analgesic Aerosol Spray. This product is a traditional Chinese herbal product used to relieve pain through a topical application to affected areas or closed wounds. The spray can also be used in the treatment of certain rheumatic conditions. The product is classified as a “specially needed drug” by the Chinese Military…

WednesdayOct 07, 2009 12:50 pm

China Wi-Max Communications, Inc. (CHWM.OB) Spearheads Broadband Initiative

China Wi-Max Communications, Inc., a Denver, Colorado-based telecommunications company formed to exploit the booming Chinese broadband market, has announced a comprehensive strategy to leverage its network foothold in Beijing. The Founder and Chairman, Dr. Allan Rabinoff, said he was pleased to announce this offering of wireless broadband to customers in Beijing and that the initiative would be led by President and CEO Steven T. Berman. Rabinoff went on to say that Mr. Berman would “play a critically important role in the successful execution of our growth strategy.” Mr. Berman brings his vast 20 years of business and legal experience in…

Site Search

Company Search

Month: October 2009